Top compounds associated with response to SLC16A2


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.047 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.3
mRNA ML083 CTRPv2 pan-cancer AAC -0.049 0.3
mRNA A-443654 GDSC1000 pan-cancer AAC 0.066 0.3
mRNA Panobinostat CCLE pan-cancer AAC -0.054 0.3
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.3
mRNA Bosutinib FIMM pan-cancer AAC 0.42 0.3
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.046 0.3
mRNA BMS-754807 FIMM pan-cancer AAC -0.14 0.3
mRNA NG-25 GDSC1000 pan-cancer AAC 0.036 0.3
Download CSV